Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

224 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunosuppression without steroids in liver transplantation is safe and reduces infection and metabolic complications: results from a prospective multicenter randomized study.
Lladó L, Xiol X, Figueras J, Ramos E, Memba R, Serrano T, Torras J, Garcia-Gil A, Gonzalez-Pinto I, Castellote J, Baliellas C, Fabregat J, Rafecas A; Thosin Study Group. Lladó L, et al. Among authors: fabregat j. J Hepatol. 2006 Apr;44(4):710-6. doi: 10.1016/j.jhep.2005.12.010. Epub 2006 Jan 24. J Hepatol. 2006. PMID: 16487622 Clinical Trial.
Successful reuse of liver grafts after death of the first recipient.
Castellote J, Lladó L, Xiol X, Julià D, Ballester R, Ramos E, Fabregat J, Rafecas A. Castellote J, et al. Among authors: fabregat j. Clin Transplant. 2006 Sep-Oct;20(5):604-8. doi: 10.1111/j.1399-0012.2006.00524.x. Clin Transplant. 2006. PMID: 16968486 Review.
Impact of immunosuppression without steroids on rejection and hepatitis C virus evolution after liver transplantation: results of a prospective randomized study.
Lladó L, Fabregat J, Castellote J, Ramos E, Xiol X, Torras J, Serrano T, Baliellas C, Figueras J, Garcia-Gil A, Rafecas A; THOSIN Study Group. Lladó L, et al. Among authors: fabregat j. Liver Transpl. 2008 Dec;14(12):1752-60. doi: 10.1002/lt.21629. Liver Transpl. 2008. PMID: 19025919 Free article. Clinical Trial.
Liver retransplantation in HIV-infected patients: a prospective cohort study.
Gastaca M, Aguero F, Rimola A, Montejo M, Miralles P, Lozano R, Castells L, Abradelo M, Mata Mde L, San Juan Rodríguez F, Cordero E, Campo Sd, Manzardo C, de Urbina JO, Pérez I, Rosa Gde L, Miro JM; FIPSE OLT-HIV investigators. Gastaca M, et al. Am J Transplant. 2012 Sep;12(9):2465-76. doi: 10.1111/j.1600-6143.2012.04142.x. Epub 2012 Jun 15. Am J Transplant. 2012. PMID: 22703615 Free article.
Direct-acting antivirals are effective and safe in HCV/HIV-coinfected liver transplant recipients who experience recurrence of hepatitis C: A prospective nationwide cohort study.
Manzardo C, Londoño MC, Castells L, Testillano M, Luis Montero J, Peñafiel J, Subirana M, Moreno A, Aguilera V, Luisa González-Diéguez M, Calvo-Pulido J, Xiol X, Salcedo M, Cuervas-Mons V, Manuel Sousa J, Suarez F, Serrano T, Ignacio Herrero J, Jiménez M, Fernandez JR, Giménez C, Del Campo S, Esteban-Mur JI, Crespo G, Moreno A, de la Rosa G, Rimola A, Miro JM; FIPSE LT-HIV investigators. Manzardo C, et al. Am J Transplant. 2018 Oct;18(10):2513-2522. doi: 10.1111/ajt.14996. Epub 2018 Aug 13. Am J Transplant. 2018. PMID: 29963780 Free article.
Efficacy and Safety of Delayed Prolonged-Release Tacrolimus Initiation in De Novo Hepatitis C Virus-Negative Orthotopic Liver Transplant Recipients: A Single-Center, Single-Arm, Prospective Study.
Lladó L, González-Castillo A, Fabregat J, Baliellas C, Ramos E, González-Vilatarsana E, Busquets J, Xiol X. Lladó L, et al. Among authors: fabregat j. Ann Transplant. 2019 Jan 18;24:36-44. doi: 10.12659/AOT.912444. Ann Transplant. 2019. PMID: 30655498 Free PMC article.
224 results